Clinical Trial Update: Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM) [NA]

View source ↗

Summary

Clinical trial evaluating CorMatrix ECM Particulate (P-ECM) for restoring myocardial function in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CorMatrix ECM Particulate (extracellular matrix particulate)

Snippet

Sponsor: Corvivo Cardiovascular, Inc. | Conditions: Heart Failure | NA | Status: COMPLETED